Cargando…
‘It’s a fragile open door’—enhancing COVID-19 vaccination rates in people receiving treatment for substance use disorder
BACKGROUND: People with substance use disorder are at high risk of harms from COVID-19 infection. Vaccine hesitancy is common in this population and compounds pre-existing barriers to accessing health care. A drug and alcohol service in Sydney, Australia introduced strategies to enhance COVID-19 vac...
Autores principales: | Murnion, Bridin, Carland, Jane E, Jefferies, Meryem, Au, Michael, Tracy, Marguerite |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687600/ https://www.ncbi.nlm.nih.gov/pubmed/37709530 http://dx.doi.org/10.1093/pubmed/fdad181 |
Ejemplares similares
-
Therapeutic drug monitoring in oncology - What’s out there: A bibliometric evaluation on the topic
por: Stojanova, Jana, et al.
Publicado: (2022) -
Experiences of misuse and symptoms of dependence among people who use gabapentinoids: a qualitative systematic review protocol
por: McNeilage, Amy Gray, et al.
Publicado: (2023) -
Current Insights on the Impact of Gamma-Hydroxybutyrate (GHB) Abuse
por: Tay, Emma, et al.
Publicado: (2022) -
Do gabapentin or pregabalin directly modulate the µ receptor?
por: Manandhar, Preeti, et al.
Publicado: (2021) -
The open door /
por: Howard, Blanche Willis, 1847-1898
Publicado: (1889)